Virginia governor vetoes bill to create advisory board to reduce drug prices
Virginia Gov. Glenn Youngkin vetoed legislation late Monday that would have established an advisory board to better manage the state’s prescription drug costs. Other states have launched such advisory boards in recent months as part of growing efforts to set ceiling prices for certain high-cost treatments.
Youngkin said he vetoed the bill because the legislation didn’t take individual patients’ needs into consideration. The legislation would have allowed a Virginia prescription drug advisory board to place price caps on the state’s payments to pharma companies, allowing for up to 12 caps per year between 2025 and 2028.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
